PPT-Revolutionising the Lifecycle of Pharmaceuticals

Eyeforpharma RWD conference June 5 2013 1 Topics Introduction to CASMI Current lifecycle and its issues Forces shaping the future Adaptive licensing and its consequences Real world data and its role. of . Pharmaceutical Mixtures:. -. empirical . knowledge, gaps and regulatory options. Thomas Backhaus . University of Gothenburg . thomas.backhaus@gu.se. [T]here are . known . knowns. ; there are things we know that we know. Christina Hansen, . pharm.d. CHARACTERISTICS. Treat complex and rare disease states. RA, Cancer, Crohn’s, MS. More expensive . Distribution restrictions . Special handling requirements. Continuous monitoring. Sally Bing. Dental Hygienists are…. At School. The Real World. Reality Check. Complete the Puzzle. Complete the Puzzle – Be a Coach. Build a Relationship. Be a True Listener. Inspire. Build a . RElationship. PERFORMANCE SOLUTIONS. Current Maintenance Practices. Can you say with . high. confidence that current completion of maintenance activities is delivering measurable results?. Do you at times feel frustrated at continuously approving expenses without knowing what the “end goal” is?. Proposed Rule. October 20, 2015. SBEAP Technical Subcommittee. Outline of Today’s Briefing. 2. Part I: Background. Which Pharmaceuticals are Hazardous Waste?. Flow of Pharmaceuticals & Problem Areas. eManifest. , . & Biennial Reporting. . Prepared by: Bret . Reburn. Environmental Specialist 3. Hazardous Waste . Enforcement. Central Regional Office - Trenton, NJ. (609. ) . 292-3949. bret.reburn@dep.nj.gov. eManifest. , . & Biennial Reporting. . Prepared by: Bret . Reburn. Environmental Specialist 3. Hazardous Waste . Enforcement. Central Regional Office - Trenton, NJ. (609. ) . 292-3949. bret.reburn@dep.nj.gov. April 19, 2018. Dr. Rania Bader,. HRH2030 . Health Workforce Competency Lead. HRH2030. The Human Resources for Health (HRH2030) is a five-year USAID-funded activity that supports the Ministry of Health (MOH), High Health Council (HHC), and other national health stakeholders to strengthen the health workforce to improve the delivery of health services. . Presented by: Tania K. Rapoza. Agenda. Accenture. Enterprise Transformation. Product . Innovation (PI). Product . Lifecycle . Management (PLM). . Global Challenges. PLM Assets and Services. Conclusion. © Copyright 2018 - HR Pharmaceuticals. Who We Are. We are a manufacturer. of premium quality consumables.. Our. focus is on the Medical, Consumer . and Animal Health markets. . Since HR® Lubricating Jelly in 1931 and . Guido Sandulli. Director of Marketing – Merit Medical. Agenda. Background. Academia vs Real World. Marketing’s Role. Pre-Launch – Upstream Marketing. Product Launch . Lifecycle Management. Background. School of Public HealthTHE ROLE OF PHARMACEUTICALS IN PUBLIC HEALTHACCESS TO ESSENTIAL MEDICINES AS A KEYDETERMINANT TO UNIVERSAL HEALTH COVERAGESeptember 15 2016Boston University School of Public He This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translation, the former shall p Total hospital and physician. costs, 2013. a. Diagnostic imaging prices, 2013. a. Price comparison for in-patent pharmaceuticals, 2010 . (U.S. set to 100). b. Bypass. surgery. Appendectomy. MRI. CT scan.